Assignee
CSL LTD
US87 patents
Top patents by PatentIndex Score
US6306397B1Oct 23, 2001
Variants of human papilloma virus antigens
CSL LTD46 citations94
US6093324AJul 25, 2000
Purification of immunoglobulins
CSL LTD102 citations93
US7993637B2Aug 9, 2011
IL-11 muteins
CSL LTD20 citations92
US9956269B2May 1, 2018
Method for improving the stability of purified factor VIII after reconstitution
CSL LTD12 citations91
US9340618B2May 17, 2016
IL-11R binding proteins
CSL LTD22 citations91
US9125943B2Sep 8, 2015
Reconstituted HDL formulation
CSL LTD17 citations91
US6685947B1Feb 3, 2004
T helper cell epitopes
CSL LTD21 citations91
US6004557ADec 21, 1999
Variants of human papillomavirus antigens
CSL LTD36 citations91
US5593697AJan 14, 1997
Single dose vaccination system
CSL LTD94 citations91
US9439946B2Sep 13, 2016
Reconstituted high density lipoprotein formulation and production method thereof
CSL LTD10 citations90
US7419671B2Sep 2, 2008
P. gingivalis antigenic composition
CSL LTD24 citations90
US7776343B1Aug 17, 2010
Immunogenic complexes and methods relating thereto
CSL LTD21 citations89
US7114617B2Oct 3, 2006
Container
CSL LTD24 citations88
US6365160B1Apr 2, 2002
Papillomavirus polyprotein constructs
CSL LTD42 citations88
US5902565AMay 11, 1999
Spray dried vaccine preparation comprising aluminium adsorbed immunogens
CSL LTD70 citations88
US6444799B1Sep 3, 2002
P. gingivalis polynucleotides and uses thereof
CSL LTD35 citations86
US5917022AJun 29, 1999
Process for removing endotoxins
CSL LTD36 citations86
US7204991B2Apr 17, 2007
Porphyromonas gingivalis recombinant proteins and truncations
CSL LTD25 citations85
US10537616B2Jan 21, 2020
Method for improving the stability of purified factor VIII after reconstitution
CSL LTD5 citations83
US9394353B2Jul 19, 2016
Method for improving the stability of purified factor VIII after reconstitution
CSL LTD9 citations83
US11058747B2Jul 13, 2021
Reconstituted high density lipoprotein formulation and production method thereof
CSL LTD3 citations82
US10603355B2Mar 31, 2020
Reconstructed HDL formulation
CSL LTD4 citations82
US10335457B2Jul 2, 2019
Reconstituted high density lipoprotein formulation and production method thereof
CSL LTD5 citations82
US9925236B2Mar 27, 2018
Reconstituted HDL formulation
CSL LTD7 citations82
US6428807B1Aug 6, 2002
Chelating immunostimulating complexes
CSL LTD45 citations82
US10087235B2Oct 2, 2018
Contaminant removal method
CSL LTD4 citations81
USD487342SMar 9, 2004
Pharmaceutical product container
CSL LTD13 citations80
US6129923AOct 10, 2000
Treatment of H. pylori associated gastroduodenal disease
CSL LTD15 citations80
US6960463B2Nov 1, 2005
Separation of fibrinogen from plasma proteases
CSL LTD13 citations75
US9878017B2Jan 30, 2018
Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating thereto
CSL LTD4 citations73
US7169585B2Jan 30, 2007
Papillomavirus vaccine
CSL LTD6 citations73
US10881717B2Jan 5, 2021
Method for improving the stability of purified Factor VIII after reconstitution
CSL LTD3 citations72
US10047161B2Aug 14, 2018
Humanized anti-interleukin 3 receptor alpha chain antibodies
CSL LTD2 citations72
US11464828B2Oct 11, 2022
Reconstituted HDL formulation
CSL LTD3 citations71
US10421799B2Sep 24, 2019
Process for preparing Apolipoprotein A-I (Apo A-I)
CSL LTD1 citations71
US9890203B2Feb 13, 2018
Process for preparing apolipoprotein A-I (Apo A-I)
CSL LTD2 citations71
US9796782B2Oct 24, 2017
Fibronectin III domain of IL-11Rα
CSL LTD3 citations71
US6303128B1Oct 16, 2001
Method for protein expression
CSL LTD8 citations71
US5871749AFeb 16, 1999
Therapeutic treatment of H. pylori associated gastroduodenal disease
CSL LTD14 citations71
US10730927B2Aug 4, 2020
Contaminant removal method
CSL LTD2 citations70
US9758585B2Sep 12, 2017
Compositions and methods for targeting type 1 interferon producing cells
CSL LTD2 citations70
US6726912B1Apr 27, 2004
Papillomavirus polyprotein constructs
CSL LTD8 citations69
US10961304B2Mar 30, 2021
Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)
CSL LTD2 citations68
US9803008B2Oct 31, 2017
Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)
CSL LTD2 citations68
US10894834B2Jan 19, 2021
CD131 binding proteins
CSL LTD2 citations67
US7534441B2May 19, 2009
Immunogenic LHRH compositions and methods relating thereto
CSL LTD7 citations65
US6815535B1Nov 9, 2004
Purification of fibrinogen
CSL LTD10 citations63
US6593296B1Jul 15, 2003
Stabilized growth hormone formulation and method of preparation thereof
CSL LTD8 citations63
US9777062B2Oct 3, 2017
High affinity antibody antagonists of interleukin-13 receptor alpha 1
CSL LTD1 citations62
US9371388B2Jun 21, 2016
High affinity antibody antagonists of interleukin-13 receptor alpha 1
CSL LTD2 citations62
Showing the top 50 of 87 patents by PatentIndex Score.